Abu Dhabi sets out AI drug research and clinical-trial plans
Agreements include a 24-month roadmap and feasibility assessment of up to 30 trials by 2030.
- Publish date: 2026-10-21
- Category: Standards & Policy
- Original source: Emirates News Agency (WAM)
- Reading time: 1 min read
Abu Dhabi Health and Isomorphic Labs plan a 24-month roadmap for selected AI pre-clinical drug-discovery projects. The department, Cleveland Clinic Abu Dhabi and AstraZeneca will assess the feasibility of up to 30 trials by 2030. The agreements could deliver estimated life-sciences research investment of AED 180 million.